Showing posts for Coronavirus

Clear

Major rise in public support for COVID vaccine – Oxford study

Major rise in public support for COVID vaccine – Oxford study

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Vaccine passports can work but face 12 challenges

Vaccine passports can work but face 12 challenges

World’s largest clinical trial for COVID-19 treatments expands internationally

World’s largest clinical trial for COVID-19 treatments expands internationally

Deliberate vaccine misinformation should be held to account - but better information is essential

Deliberate vaccine misinformation should be held to account - but better information is essential

Oxford-led technology to help those at high risk from Covid-19

Oxford-led technology to help those at high risk from Covid-19

Oxford coronavirus vaccine children's study - FAQs

Oxford coronavirus vaccine children's study - FAQs

Oxford University extends COVID-19 vaccine study to children

Oxford University extends COVID-19 vaccine study to children

Tocilizumab reduces deaths in patients hospitalised with COVID-19

Tocilizumab reduces deaths in patients hospitalised with COVID-19

World Health Organization experts provide guidance on use of the Oxford vaccine

World Health Organization experts provide guidance on use of the Oxford vaccine

Drug trial that could improve respiratory recovery from COVID-19 now underway

Drug trial that could improve respiratory recovery from COVID-19 now underway

Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests

Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests

NHS COVID-19 contact tracing app averted between 200,000 and 900,000 infections, estimates infectious disease experts

NHS COVID-19 contact tracing app averted between 200,000 and 900,000 infections, estimates infectious disease experts

ChAdOx1 nCov-19 provides minimal protection against mild-moderate COVID-19 infection from B.1.351 coronavirus variant in young South African adults

ChAdOx1 nCov-19 provides minimal protection against mild-moderate COVID-19 infection from B.1.351 coronavirus variant in young South African adults

Oxford vaccine effective against major B.1.1.7 ‘Kent’ coronavirus strain circulating in the UK

Oxford vaccine effective against major B.1.1.7 ‘Kent’ coronavirus strain circulating in the UK